Section 4.1: Differentials in Cardiovascular Conditions

Differentials in Cardiovascular Conditions

Primary care clinical practice requires a systematic approach to differentiating common cardiovascular pathologies. The Family Nurse Practitioner (FNP) must analyze clinical risk factors, physiological presentations, and diagnostic indicators to distinguish among primary and secondary hypertension, lipid disorders, cardiac murmurs, coronary artery disease (CAD), and heart failure.

1. Hypertension: Primary vs. Secondary Etiologies

Hypertension affects nearly half of the adult population in the United States. According to the 2017 ACC/AHA guidelines, blood pressure is classified as:

• Normal: <120 mmHg systolic and <80 mmHg diastolic.
• Elevated: 120–129 mmHg systolic and <80 mmHg diastolic.
• Stage 1 Hypertension: 130–139 mmHg systolic or 80–89 mmHg diastolic.
• Stage 2 Hypertension: >=140 mmHg systolic or >=90 mmHg diastolic.

While primary (essential) hypertension accounts for 90–95% of adult cases, identifying secondary hypertension is a critical competency for the FNP. Secondary hypertension should be suspected in patients with:

• Sudden or severe onset of hypertension.
• Age of onset <30 years (especially in non-obese patients without a family history) or >55 years.
• Drug-resistant hypertension, defined as blood pressure that remains uncontrolled despite the concurrent use of three antihypertensive agents of different classes (one of which must be a diuretic) at optimal doses.
• Accelerated or malignant hypertension (severe elevations with signs of target organ damage).

The differential diagnosis for secondary hypertension includes several primary conditions:

1. Renal Artery Stenosis (RAS): The most common correctable cause of secondary hypertension. It presents as fibromuscular dysplasia in young females or atherosclerosis in older adults. Key clinical signs include an abdominal flank bruit with a systolic-diastolic component, sudden worsening of renal function, or an acute rise in serum creatinine of >30% after initiating an Angiotensin-Converting Enzyme Inhibitor (ACE-I) or Angiotensin Receptor Blocker (ARB).
2. Primary Aldosteronism (Conn's Syndrome): Characterized by autonomous overproduction of aldosterone, leading to sodium retention and potassium wasting. Clinical signs include unexplained hypokalemia (often exacerbated by low-dose diuretics), muscle weakness, or cramping. The diagnosis is supported by an elevated plasma aldosterone concentration (PAC) and suppressed plasma renin activity (PRA), yielding a PAC/PRA ratio >20.
3. Pheochromocytoma: A rare catecholamine-secreting tumor of the adrenal medulla. It presents with the classic triad of episodic headaches, generalized diaphoresis, and palpitations/tachycardia, typically accompanied by severe, paroxysmal hypertension. Diagnostic screening involves measuring fractionated plasma metanephrines or 24-hour urinary metanephrines.
4. Coarctation of the Aorta: A congenital narrowing of the aorta. It typically presents in young adults with a systolic murmur heard over the back, delayed femoral pulses when compared to radial pulses (radial-femoral delay), and a significant blood pressure discrepancy between the upper and lower extremities (higher in the arms than the legs).
5. Obstructive Sleep Apnea (OSA): Strongly associated with resistant hypertension. Risk factors include obesity, a large neck circumference (>17 inches in men, >16 inches in women), daytime somnolence, and loud snoring. Differentiating OSA requires a sleep study (polysomnography).

2. Lipid Disorders and Cardiovascular Risk

Dyslipidemia is a major modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD). The FNP must differentiate between primary dyslipidemias, which are genetic disorders of lipid metabolism, and secondary dyslipidemias, which result from underlying clinical conditions or medications.

• Primary Dyslipidemias: Familial Hypercholesterolemia (FH) is characterized by severely elevated low-density lipoprotein cholesterol (LDL-C) levels (often >190 mg/dL in adults). Physical signs include tendon xanthomas (particularly on the Achilles tendon) and corneal arcus in patients under age 45.
• Secondary Dyslipidemias: Underlying causes include hypothyroidism (which decreases LDL receptor expression), nephrotic syndrome (leading to hepatic overproduction of lipids), obstructive liver disease (biliary obstruction), uncontrolled diabetes mellitus, excessive alcohol intake (which increases triglycerides), and medications such as thiazide diuretics, beta-blockers, and atypical antipsychotics. Risk stratification must utilize the ACC/AHA 10-year ASCVD Risk Estimator, which integrates age, sex, race, blood pressure, cholesterol levels, diabetes status, and smoking history to determine the appropriate intensity of statin therapy (high, moderate, or low).

3. Valvular Murmurs: Systolic vs. Diastolic Identification

Differentiating cardiac murmurs requires evaluating their timing (systolic vs. diastolic), location of maximal intensity, radiation, and dynamic changes with physical maneuvers.

Systolic Murmurs

• Aortic Stenosis (AS): A harsh, crescendo-decrescendo murmur loudest at the right upper sternal border (RUSB) that radiates to the carotid arteries. It is associated with a delayed and weak carotid pulse (pulsus parvus et tardus). The murmur decreases in intensity with standing or the Valsalva maneuver (which reduces venous return/preload) and increases with squatting (which increases preload).
• Mitral Regurgitation (MR): A blowing, holosystolic murmur loudest at the apex that radiates to the left axilla. It increases with handgrip (which increases afterload) and squatting.
• Mitral Valve Prolapse (MVP): Characterized by a mid-systolic click followed by a late-systolic murmur. Physical maneuvers that decrease left ventricular volume (e.g., standing, Valsalva) cause the click and murmur to occur earlier in systole, whereas maneuvers that increase preload or afterload (e.g., squatting, handgrip) delay the click and murmur.
• Physiological (Innocent) Murmurs: Mid-systolic, soft (Grade I–II/VI), loudest at the left sternal border, and asymptomatic, without radiation or structural cardiac anomalies. They typically disappear with standing.

Diastolic Murmurs

Diastolic murmurs are always pathological and require an echocardiogram.

• Aortic Regurgitation (AR): A high-pitched, blowing, decrescendo murmur loudest at the left upper sternal border (Erb's point) with the patient sitting up and leaning forward. It is associated with a wide pulse pressure and a bounding "Water-hammer" pulse.
• Mitral Stenosis (MS): A low-pitched, rumbling diastolic murmur loudest at the apex in the left lateral decubitus position, preceded by an opening snap.

4. Coronary Artery Disease and Angina

When evaluating chest pain, the FNP must differentiate stable angina, unstable angina, and acute coronary syndrome (ACS) from non-cardiac etiologies.

• Stable Angina: Predictable, transient chest discomfort provoked by exertion or emotional stress, lasting less than 15 minutes, and relieved by rest or sublingual nitroglycerin.
• Unstable Angina / ACS: Chest pain that occurs at rest, is new-onset, or exhibits an accelerating pattern (increased frequency, severity, or duration). Electrocardiogram (ECG) changes may show ST-segment depression or T-wave inversion.
• Myocardial Infarction (NSTEMI vs. STEMI): Distinguished by the presence of elevated cardiac biomarkers (Troponin I or T). STEMI presents with ST-segment elevation in two or more contiguous leads, representing transmural ischemia, while NSTEMI shows biomarker elevation without persistent ST elevation.
• Non-Cardiac Chest Pain: Differentiated via history and exam. GERD presents with retrosternal burning exacerbated by lying flat and relieved by antacids. Costochondritis is characterized by localized chest wall tenderness elicited by palpation of the costochondral joints.

5. Heart Failure: Phenotypes and Staging

Heart failure (HF) is a complex clinical syndrome resulting from structural or functional impairment of ventricular filling or ejection. Differentiating the underlying phenotype and staging is essential for management:

• HFrEF (Systolic HF): Ejection fraction <=40%. Characterized by impaired myocardial contractility, ventricular dilation, and an S3 gallop. Common causes include ischemic heart disease and dilated cardiomyopathy.
• HFpEF (Diastolic HF): Ejection fraction >=50%. Characterized by impaired ventricular relaxation and stiffness, normal chamber size, and an S4 gallop (due to atrial contraction against a stiff ventricle). Common causes include chronic hypertension and myocardial hypertrophy.
• Left-sided vs. Right-sided Symptoms: Left-sided failure causes pulmonary congestion (dyspnea, orthopnea, paroxysmal nocturnal dyspnea, and bibasilar crackles). Right-sided failure leads to systemic venous congestion (jugular venous distension [JVD], hepatojugular reflux, hepatomegaly, splenomegaly, and peripheral edema).
• Staging and Functional Classification: The FNP must distinguish the ACC/AHA Stages (Stage A to D, representing progressive risk and structural disease) from the NYHA Functional Classes (Class I to IV, representing current subjective symptom severity).